Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonistAnna Rizzi, Girolamo Calò, Claudio Trapella et al.|Pharmacology Research & Perspectives|2016Cited by 65
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trialsCecilia Eleuteri, Cristina Agresti, Girolamo Calò et al.|Scientific Reports|2017Cited by 38
In vitro pharmacological characterization of a novel unbiased <scp>NOP</scp> receptor‐selective nonpeptide agonist <scp>AT</scp>‐403Federica Ferrari, Nurulain T. Zaveri, Davide Malfacini et al.|Pharmacology Research & Perspectives|2017Cited by 31
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13)Maria Camilla Cerlesi, Remo Guerrini, Huiping Ding et al.|European Journal of Pharmacology|2016Cited by 27
Modulation of Drosophila suzukii type 1 tyramine receptor (DsTAR1) by monoterpenes: a potential new target for next generation biopesticidesLuca Finetti, Giovanni Bernacchia, Federica Ferrari et al.|Pesticide Biochemistry and Physiology|2020Cited by 23